Abstract:Background Inhibitor of differentiation 2 ( Id2 ) is a critical factor for cell proliferation and differentiation in normal vertebrate development. Most of the biological function of Id2 has been ascribed to its helix-loop-helix motif. Overexpression of Id2 is frequently observed in various human tumors, but its role for invasion potential in tumor cells is dispute. We aimed to reveal the role of Id2 in invasion potential in poorly invasive and estrogen receptor α (ERα)-positive MCF-7 and SKOV-3 cancer cells. Methods MCF-7 and SKOV-3 cells were stably transfected with the wild-type, degradation-resistant full-length or helix-loop-helix (HLH)-deleted Id2, respectively. Protein levels of Id2 and its mutants and E-cadherin were determined by western blot analysis and mRNA levels of Id2 and its mutants were determined by RT-PCR. The effects of Id2 and its mutants on cell proliferation were determined by [ 3 H]-thymidine incorporation assay and the 3- [4, 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) dye method. The in vitro invasion potential of cells was evaluated by Transwell assay. Cell motility was assessed by scratch wound assay. The promoter activity of E-cadherin was determined by cotransfection and luciferase assays. Results Ectopic transfection of the wild-type Id2 markedly increased the protein and mRNA expression of Id2 in MCF-7 and SKOV-3 cells; the protein level but not mRNA level was further increased by transfection with the degradation-resistant Id2 form. The ectopic expression of Id2 or its mutants did not alter proliferation of either MCF-7 or SKOV-3 cells. Transfection of the wild-type Id2 significantly induced the invasion potential and migratory capacity of cells, which was further augmented by transfection with the degradation-resistant full-length or HLH-deleted Id2. E-cadherin protein expression and transactivation of the proximal E-cadherin promoter were markedly suppressed by the degradation-resistant full-length or HLH-deleted Id2 but not wild-type Id2. Ectopic expression of E-cadherin in MCF-7 and SKOV-3 cells only partially blunted the invasion potential induced by the degradation-resistant HLH-deleted Id2. Conclusion Overexpression of Id2 in ERα-positive epithelial tumor cells indeed increases the cells' invasive potential through a novel mechanism independent of dimerization to basic helix-loop-helix factors. E-cadherin contributes only in part to Id2-induced cell invasion when Id2 is accumulated to a higher level in some specific cell types.

FHL2 Interacts with and Acts As a Functional Repressor of Id2 in Human Neuroblastoma Cells

FHL2 Antagonizes Id1-Promoted Proliferation and Invasive Capacity of Human MCF-7 Breast Cancer Cells

FHL2 Inhibits the Id3-promoted Proliferation and Invasive Growth of Human MCF-7 Breast Cancer Cells.

Oncogene Functions of FHL2 Are Independent from NF-κBIα in Gastrointestinal Cancer

Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors

Suppression of FHL2 Expression Induces Cell Differentiation and Inhibits Gastric and Colon Carcinogenesis

The Four-and-a-half-lim Protein 2 (FHL2) is Overexpressed in Gliomas and Associated with Oncogenic Activities.

Downregulation of Id2 Increases Chemosensitivity of Glioma

Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1.

Inhibitor of DNA binding 2 promotes axonal growth through upregulation of Neurogenin2.

Inhibitor of DNA Binding 2 Knockdown Inhibits the Growth and Liver Metastasis of Colorectal Cancer.

Id2 expression increases with differentiation of human myeloid cells

CSIG-19. FHL2 INTERACTS WITH EGFRVIII TO PROMOTE GLIOBLASTOMA GROWTH

Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors

Id2 Collaborates with Id3 to Suppress Invariant NKT and Innate-like Tumors

Id2-Dependent Anti-Tumor Immunity Promotes Anti-Cancer Therapies Effects

Inhibitor of Binding/differentiation 2 (id2) is Regulated by CCAAT/enhancer-binding Protein-Α (c/ebpα) and Promotes the Proliferation of Hepatocellular Carcinoma.

Four and a Half LIM Protein 2 (FHL2) Negatively Regulates the Transcription of E-cadherin Through Interaction with Snail1.

Four-and-a-half LIM Protein 2 Promotes Invasive Potential and Epithelial-Mesenchymal Transition in Colon Cancer.

The role of FHL1 in tumors

Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition Via Up-Regulation of Notch3 in Breast Cancer